" /> Pyridoxamine 5-prime-phosphate oxidase deficiency - CISMeF





Preferred Label : Pyridoxamine 5-prime-phosphate oxidase deficiency;

Symbol : PNPOD;

CISMeF acronym : PNPOD;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Pnpo deficiency; Epileptic encephalopathy, neonatal, pnpo-related; Seizures, pyridoxine-resistant, plp-sensitive;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the pyridoxamine 5-prime-phosphate oxidase gene (PNPO, 603287.0001);

Laboratory abnormalities : Increased blood lactate; Hypoglycemia; Normal to increased plasma glycine; Normal to increased plasma threonine; Decreased plasma arginine; Decreased CSF arginine; Increased urine vanillactic acid (VLA); Decreased CSF 5-hydroxyindoleacetic acid (5HIAA); Increased CSF glycine; Decreased CSF homovanillic acid (HVA); Increased CSF threonine; Increased CSF 3-methoxytyrosine (3-MT); Increased CSF histidine; Increased CSF taurine; Decreased CSF pyridoxal 5-prime-phosphate (PLP);

Prefixed ID : #610090;

Details


You can consult :


Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.